These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 8592679

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Ligand-induced downregulation of receptor-mediated clearance of hepatocyte growth factor in rats.
    Liu KX, Kato Y, Kino I, Nakamura T, Sugiyama Y.
    Am J Physiol; 1998 Nov; 275(5):E835-42. PubMed ID: 9815004
    [Abstract] [Full Text] [Related]

  • 3. Existence of two nonlinear elimination mechanisms for hepatocyte growth factor in rats.
    Liu KX, Kato Y, Kato M, Kaku TI, Nakamura T, Sugiyama Y.
    Am J Physiol; 1997 Nov; 273(5):E891-7. PubMed ID: 9374673
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Decrease in the hepatic clearance of hepatocyte growth factor in carbon tetrachloride-intoxicated rats.
    Liu KX, Kato Y, Yamazaki M, Higuchi O, Nakamura T, Sugiyama Y.
    Hepatology; 1993 Apr; 17(4):651-60. PubMed ID: 8477970
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The pharmacokinetics, tissue localization, and metabolic processing of recombinant human hepatocyte growth factor after intravenous administration in rats.
    Zioncheck TF, Richardson L, DeGuzman GG, Modi NB, Hansen SE, Godowski PJ.
    Endocrinology; 1994 Apr; 134(4):1879-87. PubMed ID: 8137756
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficient extraction by the liver governs overall elimination of hepatocyte growth factor in rats.
    Kato M, Kato Y, Nakamura T, Sugiyama Y.
    J Pharmacol Exp Ther; 1999 Jul; 290(1):373-9. PubMed ID: 10381802
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Safety and pharmacokinetics of recombinant human hepatocyte growth factor (rh-HGF) in patients with fulminant hepatitis: a phase I/II clinical trial, following preclinical studies to ensure safety.
    Ido A, Moriuchi A, Numata M, Murayama T, Teramukai S, Marusawa H, Yamaji N, Setoyama H, Kim ID, Chiba T, Higuchi S, Yokode M, Fukushima M, Shimizu A, Tsubouchi H.
    J Transl Med; 2011 May 08; 9():55. PubMed ID: 21548996
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.